Bioprocessing of oncolytic group B adenovirus for scalable production
<p>The central aim of this thesis was to develop strategies to improve the manufacture of the group B chimeric oncolytic adenovirus, ColoAd1, which rapidly kills and lyses host cells. In attempting to improve the cellular yield of ColoAd1, this thesis therefore sought to identify host infectio...
المؤلف الرئيسي: | Cooper, L |
---|---|
مؤلفون آخرون: | Seymour, L |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2014
|
الموضوعات: |
مواد مشابهة
-
Oncolytic Adenoviruses in Cancer Treatment
حسب: Ramon Alemany
منشور في: (2014-02-01) -
Oncolytic adenoviruses and immunopeptidomics: a convenient marriage
حسب: Marc Garcia‐Moure, وآخرون
منشور في: (2024-04-01) -
Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
حسب: Janet Lei, وآخرون
منشور في: (2018-06-01) -
Oncolytic Replication of E1b-Deleted Adenoviruses
حسب: Pei-Hsin Cheng, وآخرون
منشور في: (2015-11-01) -
A Renaissance for Oncolytic Adenoviruses?
حسب: Paola Blanchette, وآخرون
منشور في: (2023-01-01)